GOSS - Gossamer Bio Inc
Gossamer Bio Inc Logo

GOSS - Gossamer Bio Inc

https://www.gossamerbio.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapies in the areas of immunology, inflammation, and oncology diseases in the United States. The company is headquartered in San Diego, California.

52W High
$2.98
52W Low
$0.66
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.95
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.39
EV/Revenue (<3 favorable)
16.36
P/S (TTM) (<3 favorable)
16.61
P/B (<3 favorable)
2.66
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
3.52%
Institutions (25–75% balanced)
78.92%
Shares Outstanding
227,381,000
Float
183,799,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
40,237,000
Gross Profit (TTM)
40,237,000
EPS (TTM)
-0.61
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-3.37%
ROE (TTM) (>15% strong)
-7.83%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.88
Momentum
Bearish momentum
Value
0.4184
Previous
0.3773
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025